Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

U.S. to boost supplies of Tpoxx to fight monkeypox outbreak

By Brian Buntz | August 18, 2022

Monkeypox

[Monkeypox images from CDC]

The Administration for Strategic Preparedness and Response (ASPR) will make 50,000 courses of the small-molecule drug Tpoxx (tecovirimat) from SIGA Technologies (Nasdaq: SIGA) available to help fight the monkeypox outbreak.

There have been 13,517 confirmed monkeypox/orthopoxvirus cases in the U.S. to date, according to the CDC.

In 2018, Tpoxx became the first drug to win an FDA indication for smallpox.

The agency approved the drug under its Animal Rule for treating smallpox using animal efficacy data and human safety data.

The FDA has authorized the use of Tpoxx to treat monkeypox patients through expanded access protocols.

The U.S. maintains a substantial inventory of the drug as part of the Strategic National Stockpile (SNS).

An announcement from the White House noted that it would allocate courses of Tpoxx with a formula based 75% on the number of cases in their jurisdiction plus 25% of the number of individuals who face an elevated risk of infection from the virus. The latter percentage includes individuals with HIV or who could benefit from HIV pre-exposure prophylaxis.

The U.S. has already allocated more than 20,000 courses of Tpoxx from the SNS.

Regulators in the EU and UK have also approved Tpoxx for monkeypox.

The U.S. also recently announced plans to provide up to 442,000 doses of the Jynneos vaccine from Bavarian Nordic A/S (OMX:BAVA) to help combat the monkeypox outbreak.

The country also will make 50,000 monkeypox vaccines available for Pride and other events with high numbers of gay men, according to CNBC.

There have been more than 39,000 monkeypox cases reported internationally.

In early August, the FDA authorized emergency use of the Jynneos monkeypox vaccine. The EUA covered the intradermal use of the vaccine in individuals with an elevated risk of infection from the virus.

The FDA concluded that the intradermal administration of the two-dose vaccine allows a fraction of the vaccine to be used rather than subcutaneously.


Filed Under: Infectious Disease
Tagged With: monkeypox, SIGA Technologies, TPOXX
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Related Articles Read More >

Secretary of Health removes all current members of the CDC advisory committee on immunization practices
covid-19 vaccine
FDA COVID booster pullback jolts vaccine stocks before gains cool
Coronavirus Covid-19 background - 3d rendering
Pregnancy associated with less long COVID: Researchers call for studies on protective biology
How technology advances are helping scientists unlock the mysteries of zoonotic diseases
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE